Cochlear | COH - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Ansell USD 238.3M 674M 2025-06
Avita Medical AUD 10.24M 1.98M 2025-12
Cochlear AUD 275.7M 107.4M 2025-06
CSL USD 2.16B 633M 2025-06
Fisher Paykel Healthcare NZD 461.1M 371.2M 2026-06
Healius AUD 60.1M 25.6M 2024-06
Integral Diagnostics AUD 17.99M 15.86M 2023-12
Mayne Pharma AUD 110.07M 838K 2024-06
Mesoblast USD 129.57M 31.58M 2025-12
Monash IVF AUD 9.43M 1.93M 2025-06
Nanosonics AUD 161.29M 156.45M 2025-06
Polynovo AUD 29.21M 16.7M 2025-12
Ramsay Health Care AUD 784.4M 443.3M 2025-06
Regis Healthcare AUD 192.46M 127.56M 2025-06
ResMed USD 1.66B 243.44M 2026-03
Sigma Healthcare AUD 16.65M 3.68M 2023-01
Somnomed AUD 11.96M 4.92M 2023-06
Sonic Healthcare AUD 645M 25.39M 2024-06
Telix Pharmaceuticals AUD 141.87M 65.29M 2025-12